Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Brain Res ; 1547: 34-42, 2014 Feb 14.
Article in English | MEDLINE | ID: mdl-24333358

ABSTRACT

Phytol, a branched chain unsaturated alcohol, is particularly interesting because it is an isolated compound from essential oils of different medicinal plants. The aim of this study was to evaluate the anxiolytic-like effects of phytol in animal models to clarify their possible action mechanism. After acute intraperitoneal treatment with phytol at doses of 25, 50 and 75 mg/kg behavioral models of open-field, elevated-plus-maze, rota-rod, light-dark, marble-burying and pentobarbital sleeping time tests were utilized. In open field test, phytol (25, 50 and 75 mg/kg) [p<0.01] increased the number of crossings and rearings. However, the number of groomings [p<0.01] was reduced. Likewise, the number of entries and the time spent in light space were increased [p<0.01] while the number of marble-burying was decreased [p<0.001], in elevated-plus-maze, light-dark and marble-burying tests, respectively. In motor activity test, phytol (75 mg/kg) impaired the rota-rod performance of mice [p<0.01]. In pentobarbital sleeping time test, phytol 75 mg/kg decreased for latency of sleeping and phytol (25, 50 and 75 mg/kg) increased the sleep time when compared to negative control [p<0.05]. All these effects were reversed by pre-treatment with flumazenil (2.5mg/kg, i.p.), similarly to those observed with diazepam (2mg/kg, i.p.; positive control) suggesting that the phytol presents mechanism of action by interaction with the GABAergic system. These findings suggest that acute administration of phytol exerts an anxiolytic-like effect on mice. Furthermore, suppose that phytol interacts with GABAA receptor, probably at the receptor subtypes that mediate benzodiazepines effects, to produce sedative and anxiolytic activities.


Subject(s)
Anti-Anxiety Agents/pharmacology , Behavior, Animal/drug effects , Phytol/pharmacology , Sleep/drug effects , Animals , Anti-Anxiety Agents/administration & dosage , Flumazenil/pharmacology , GABA Modulators/pharmacology , Male , Maze Learning/drug effects , Mice , Motor Activity/drug effects , Phytol/administration & dosage
2.
Brain Res ; 1448: 56-62, 2012 Apr 11.
Article in English | MEDLINE | ID: mdl-22364736

ABSTRACT

The aim of the study is to determine the acute toxicity and anxiolytic-like effects of a mixture of cis and trans of (+)-limonene epoxide in animal models of anxiety. After acute treatment with (+)-limonene epoxide at doses of 25, 50 and 75 mg/kg (i.p.) no mortality was noted during 14 days of observation. In general, behavior, food and water consumption showed no significant changes. In open field test, (+)-limonene epoxide at doses of 25, 50 and 75 mg/kg, after intraperitoneal administration, significantly decreased the number of crossings, grooming and rearing (p<0.001). All these effects were reversed by the pre-treatment with flumazenil (25 mg/kg, i.p.), similar to those observed with diazepam used as a positive standard. In the elevated-plus-maze test, (+)-limonene epoxide increased the time of permanence and the number of entrances in the open arms. All these effects were reversed by flumazenil, an antagonist of benzodiazepine receptors. In addition, (+)-limonene epoxide (75 mg/kg) also produced a significant inhibition of the motor coordination (p<0.01), that was reversed by flumazenil. In conclusion, the present work evidenced sedative and anxiolytic-like effects of (+)-limonene epoxide, which might involve an action on benzodiazepine-type receptors. These results indicate that the properties of (+)-limonene epoxide should be more thoroughly examined in order to achieve newer tools for management and/or treatment of central nervous system diseases and anxiolytic-like effects. The LD50 obtained for the acute toxicity studies using intraperitoneal route of administration was 4.0 g/kg. These findings suggest that acute administration of the (+)-limonene epoxide exerts an anxiolytic-like effect on mice, and it could serve as a new approach for the treatment anxiety, since it practically does not produce toxic effects.


Subject(s)
Anti-Anxiety Agents , Monoterpenes/pharmacology , Animals , Anxiety/prevention & control , Anxiety/psychology , Behavior, Animal/drug effects , Cyclohexane Monoterpenes , Diazepam/pharmacology , Dose-Response Relationship, Drug , Female , Flumazenil/pharmacology , Hypnotics and Sedatives , Injections, Intraperitoneal , Male , Mice , Motor Activity/drug effects , Postural Balance/drug effects , Stereoisomerism
3.
Pharm Biol ; 50(4): 453-7, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22129154

ABSTRACT

CONTEXT: Platonia insignis Mart. (Clusiaceae), commonly known as "bacuri," is a timber and fruit native species of the Brazilian Amazon. Some plants of the Clusiaceae family have their pharmacological properties associated with the presence of xanthone and polycyclic polyprenylated acylphloroglucinols derivatives, which have antioxidant and anticarcinogenic activities. OBJECTIVE: The aim of this study was to assess the in vivo potential of extracts, fractions, and garcinielliptone FC isolated from of Platonia insignis seeds as a natural antioxidant. MATERIALS AND METHODS: Male Wistar rats (250-280 g; 2 months old) were treated with Tween 80 0.05% dissolved in 0.9% saline (i.p, vehicle - control group), ethanol extract (EE), hexane extract (HE), dichloromethane fraction (DMF), ethyl acetate fraction (EAF), and garcinielliptone FC (GFC) isolated from P. insignis at doses 2 mg/kg (i.p.). All groups were observed for 24 h after the treatment. The antioxidant enzymatic activities [superoxide dismutase (SOD) and catalase (CAT)] were measured using spectrophotometric methods. RESULTS: There were no marked alterations in SOD and CAT activities in rat hippocampus after pretreatment with EE, HE, DMF, EAF, and GFC. However, the pretreatment with GFC induced a significantly increase of 13, 17, 19, and 13% in SOD activities when compared to EE, HE, DMF, or EAF groups, respectively. DISCUSSION AND CONCLUSION: Our findings strongly support the hypothesis that GFC isolated from P. insignis has a significant potential to be used as a natural antioxidant agent probably due to the modulation of enzymatic activity of hippocampal SOD.


Subject(s)
Antioxidants/pharmacology , Catalase/metabolism , Clusiaceae , Hippocampus/drug effects , Plant Extracts/pharmacology , Superoxide Dismutase/metabolism , Triterpenes/pharmacology , Animals , Antioxidants/chemistry , Antioxidants/isolation & purification , Clusiaceae/chemistry , Dose-Response Relationship, Drug , Hippocampus/enzymology , Male , Plant Extracts/chemistry , Plant Extracts/isolation & purification , Plants, Medicinal , Rats , Rats, Wistar , Seeds , Solvents/chemistry , Spectrophotometry , Time Factors , Triterpenes/isolation & purification , Up-Regulation
4.
Epilepsy Behav ; 22(4): 678-84, 2011 Dec.
Article in English | MEDLINE | ID: mdl-22056341

ABSTRACT

The aim of present study was to examine the effects of the ethyl acetate fraction (EAF) from Platonia insignis on lipid peroxidation level, nitrite formation, and superoxide dismutase and catalase activities in rat striatum prior to pilocarpine-induced seizures as well as to explore its anticonvulsant activity in adult rats prior to pentylenetetrazole (PTZ)- and picrotoxin (PIC)-induced seizures. Wistar rats were treated with vehicle, atropine (25mg/kg), EAF (0.1, 1, and 10mg/kg), pilocarpine (400mg/kg, P400 group), PTZ (60 mg/kg, PTZ group), PIC (8 mg/kg, PIC group), atropine+P400, EAF+P400, EAF+PTZ, or EAF+PIC. Significant decreases in number of crossings and rearings were observed in the P400 group. The EAF 10+P400 group also had significant increases in these parameters. In addition, in rats treated with P400, there were significant increases in lipid peroxidation and nitrite levels; however, there were no alterations in SOD and catalase activities. In the EAF 10+P400 group, lipid peroxidation and nitrite levels significantly decreased and SOD and catalase activities significantly increased after pilocarpine-induced seizures. Additionally, effects of the EAF were evaluated in PTZ and PIC models. EAF did not increase the latency to development of convulsions induced with PTZ and PIC at the doses tested. Our findings strongly support the hypothesis that EAF does not have anticonvulsant activity in the different models of epilepsy studied. Our results indicate that in the in vivo model of pilocarpine-induced seizures, EAF has antioxidant activity, but not anticonvulsant properties at the doses tested.


Subject(s)
Anticonvulsants/therapeutic use , Antioxidants/therapeutic use , Epilepsy/prevention & control , Manihot/chemistry , Phytotherapy/methods , Plant Preparations/therapeutic use , Acetates/pharmacology , Animals , Catalase/metabolism , Corpus Striatum/drug effects , Corpus Striatum/metabolism , Disease Models, Animal , Dose-Response Relationship, Drug , Drug Administration Schedule , Drug Compounding , Drug Interactions , Epilepsy/chemically induced , Epilepsy/pathology , Gas Chromatography-Mass Spectrometry , Lipid Peroxidation/drug effects , Male , Motor Activity/drug effects , Muscarinic Agonists/toxicity , Pentylenetetrazole/toxicity , Picrotoxin/toxicity , Pilocarpine/toxicity , Random Allocation , Rats , Rats, Wistar , Seizures/chemically induced , Seizures/drug therapy , Superoxide Dismutase/metabolism
5.
J Biomed Biotechnol ; 2011: 678673, 2011.
Article in English | MEDLINE | ID: mdl-21660140

ABSTRACT

The antioxidant and antinociceptive activities of Citrus limon essential oil (EO) were assessed in mice or in vitro tests. EO possesses a strong antioxidant potential according to the scavenging assays. Moreover, it presented scavenger activity against all in vitro tests. Orally, EO (50, 100, and 150 mg/kg) significantly reduced the number of writhes, and, at highest doses, it reduced the number of paw licks. Whereas naloxone antagonized the antinociceptive action of EO (highest doses), this suggested, at least, the participation of the opioid system. Further studies currently in progress will enable us to understand the action mechanisms of EO.


Subject(s)
Analgesics/antagonists & inhibitors , Antioxidants/pharmacology , Citrus , Free Radical Scavengers/pharmacology , Oils, Volatile/administration & dosage , Pain/drug therapy , Plant Extracts/administration & dosage , Administration, Oral , Analgesics/analysis , Animals , Antioxidants/analysis , Citrus/chemistry , Disease Models, Animal , Free Radical Scavengers/analysis , Male , Mice , Naloxone , Oils, Volatile/isolation & purification , Pain Measurement , Plant Extracts/analysis , Plant Extracts/isolation & purification , Plant Leaves/chemistry , Rutaceae
SELECTION OF CITATIONS
SEARCH DETAIL
...